9-98056813-CGCTGGA-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PM4BS1_Supporting
The NM_018946.4(NANS):βc.16_21delβ(p.Glu6_Leu7del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000205 in 1,610,690 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.000085 ( 0 hom., cov: 34)
Exomes π: 0.000014 ( 0 hom. )
Consequence
NANS
NM_018946.4 inframe_deletion
NM_018946.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.61
Genes affected
NANS (HGNC:19237): (N-acetylneuraminate synthase) This gene encodes an enzyme that functions in the biosynthetic pathways of sialic acids. In vitro, the encoded protein uses N-acetylmannosamine 6-phosphate and mannose 6-phosphate as substrates to generate phosphorylated forms of N-acetylneuraminic acid (Neu5Ac) and 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN), respectively; however, it exhibits much higher activity toward the Neu5Ac phosphate product. In insect cells, expression of this gene results in Neu5Ac and KDN production. This gene is related to the E. coli sialic acid synthase gene neuB, and it can partially restore sialic acid synthase activity in an E. coli neuB-negative mutant. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_018946.4.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.0000137 (20/1458586) while in subpopulation AFR AF= 0.000391 (13/33280). AF 95% confidence interval is 0.000231. There are 0 homozygotes in gnomad4_exome. There are 12 alleles in male gnomad4_exome subpopulation. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NANS | NM_018946.4 | c.16_21del | p.Glu6_Leu7del | inframe_deletion | 1/6 | ENST00000210444.6 | NP_061819.2 | |
TRIM14 | XM_047424162.1 | c.*29-21006_*29-21001del | intron_variant | XP_047280118.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NANS | ENST00000210444.6 | c.16_21del | p.Glu6_Leu7del | inframe_deletion | 1/6 | 1 | NM_018946.4 | ENSP00000210444 | P1 | |
NANS | ENST00000480925.1 | n.55_60del | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
NANS | ENST00000495319.1 | n.57_62del | non_coding_transcript_exon_variant | 1/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152104Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
13
AN:
152104
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000819 AC: 2AN: 244248Hom.: 0 AF XY: 0.00000750 AC XY: 1AN XY: 133370
GnomAD3 exomes
AF:
AC:
2
AN:
244248
Hom.:
AF XY:
AC XY:
1
AN XY:
133370
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1458586Hom.: 0 AF XY: 0.0000165 AC XY: 12AN XY: 725734
GnomAD4 exome
AF:
AC:
20
AN:
1458586
Hom.:
AF XY:
AC XY:
12
AN XY:
725734
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152104Hom.: 0 Cov.: 34 AF XY: 0.000108 AC XY: 8AN XY: 74294
GnomAD4 genome
AF:
AC:
13
AN:
152104
Hom.:
Cov.:
34
AF XY:
AC XY:
8
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 10, 2022 | The c.16_21delGAGCTG (p.E6_L7del) alteration is located in exon 1 (coding exon 1) of the NANS gene. This alteration consists of an in-frame deletion of 6 nucleotides between nucleotide positions c.16 and c.21, resulting in the deletion of <NA> residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 01, 2022 | This variant, c.16_21del, results in the deletion of 2 amino acid(s) of the NANS protein (p.Glu6_Leu7del), but otherwise preserves the integrity of the reading frame. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with NANS-related conditions. This variant is present in population databases (rs776860726, gnomAD 0.03%). - |
Spondyloepimetaphyseal dysplasia, Genevieve type Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at